Ro offers treatments for a wide range of conditions for millions of patients, including acne, cold sores, reproductive concerns, hair loss and obesity
Eli Lilly and Company has launched its oral GLP-1 drug, Foundayo, following FDA approval, entering a market where Novo Nordisk already has a three-month lead with oral Wegovy
Patient Reviews at 70/100 show a BBB complaint pattern and a troubling trend of support disappearing when issues arise
For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease
While it seems like they are brand new, GLP 1s have been studied since the 1980s and have been available to the public for the treatment of diabetes since 2005